Даваа–Баасан 08:30–20:00 · Бямба 09:00–16:00
Now showing 1 - 2 of 2
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Molecular epidemiological analysis of Mycobacterium tuberculosis isolates from rural population of nationwide tuberculosis prevalence survey in Mongolia
    (Mongolian National University of Medical Sciences, 2025-12-26) ;
    Tsolmon Boldoo
    ;
    Yoshiro Murase
    ;
    Tsetsegtuya Borolzoi
    ;
    Naranzul Dambaa
    Objective: Mongolia is among the 30 high-burden countries for TB and DR-TB. Whole-genome sequencing (WGS) offers precise insights into TB transmission, strain diversity, and antimicrobial resistance (AMR), which are vital for TB control strategies. This study aimed to investigate the molecular epidemiology, lineage distribution, transmission clustering, and drug resistance patterns of M.tuberculosis collected from rural areas of Mongolia using NGS.Methods: A total of 50,194 individuals were screened in a national TB prevalence survey conducted according to WHO guidelines. From rural participants, 102 TB isolates were obtained; 100 with sufficient DNA quality were subjected to WGS. Bioinformatics analyses included lineage identification, AMR mutation profiling, and phylogenetic and clustering analyses. Results: Among the 100 isolates, lineage 2 (Beijing genotype) accounted for 72.0% and lineage 4 (Euro-American) for 28.0%. The Beijing type was dominant across all regions, especially the central region (84.6%) and showed high clustering (56.4%). A total of 13 clusters (≤12 SNVs) were identified; 86.6% were Beijing strains. MDR-TB comprised 10% of isolates, with 100% of MDR-TB strains belonging to the Beijing genotype. Resistance to isoniazid (23%) was common. Mutations associated with resistance were mainly found in katG, inhA, rpoB, pncA, rpsL, rrs, and embB genes. No resistance was observed to new drugs such as bedaquiline, linezolid, or clofazimine. Conclusions: In rural of Mongolia, M. tuberculosis Lineage 2 (modern Beijing genotype) is predominant, accounting for 72% of cases, with consistent distribution across geographic locations. Beijing strains demonstrated higher drug resistance compared to Euro-American types. Importantly, no resistance was detected to newly introduced TB drugs.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Age-stratified prevalence of latent tuberculosis infection in Ulaanbaatar, Mongolia: a facility-based cross-sectional study
    (2026-09) ;
    Tumur, Enkhtsetseg
    ;
    Sharkhuu, Gundsuren
    ;
    Igarashi, Yuriko
    ;
    Ganbaatar, Gantungalag
    OBJECTIVES: Mongolia has a high tuberculosis (TB) burden. This study aimed to assess the age-specific latent TB infection (LTBI) prevalence in a healthy population in Mongolia by using interferon-gamma release assays. METHODS: This facility-based cross-sectional study was conducted from June 2024 to March 2025 in Ulaanbaatar. Eligible participants were asymptomatic, aged ≥10 years, had no previous TB treatment, and had no known contact with TB. LTBI was detected using the QuantiFERON-TB Gold Plus (QFT-Plus) assay. Sociodemographic data were collected using standardized questionnaires. RESULTS: The overall QFT-Plus positivity rate in 766 eligible participants (mean age: 38.2 years; 47.1% female) was 33.4%. Age-specific positivity increased from 7.9% (participants aged 10-19 years) to 46.1% (participants aged ≥60 years, P < 0.0001). Sex was not associated with positivity (P = 0.652), although the rate was slightly higher in women aged 40-59 years than in men. Multivariable analysis confirmed that age was a significant predictor of QFT-Plus positivity, reflecting TB prevalence. CONCLUSION: Ulaanbaatar's LTBI prevalence remains high, especially among older adults, suggesting a shift from recent transmission to remote infection reactivation. Although QFT-Plus positivity in young individuals remains high, our findings support the prioritization of targeted preventive strategies for older populations.